Oral high-dose atorvastatin treatment in relapsing-remitting multiple sclerosis.
BACKGROUND:Recent data from animal models of multiple sclerosis (MS) and from a pilot study indicated a possible beneficial impact of statins on MS. METHODOLOGY/PRINCIPAL FINDINGS:Safety, tolerability and effects on disease activity of atorvastatin given alone or in combination with interferon-beta...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2008-04-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC2276246?pdf=render |